Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
Manipulation of pre-mRNA processing is a promising approach toward overcoming disease-causing mutations and treating human diseases. We show that a combined treatment applying two splice-manipulating technologies improves therapeutic efficacies to correct mutation-induced splice defects. Previously,...
Saved in:
Main Authors: | Saskia Breuel (Author), Mariann Vorm (Author), Anja U. Bräuer (Author), Marta Owczarek-Lipska (Author), John Neidhardt (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
by: Christoph Jüschke, et al.
Published: (2021) -
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
by: Agathe Eckenfelder, et al.
Published: (2012) -
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
by: Elena Barbon, et al.
Published: (2016) -
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing Mutants
by: Dario Balestra, et al.
Published: (2016) -
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
by: Tobias Bonifert, et al.
Published: (2016)